C12Y 118/01003
Ferredoxin--nad+ reductase
Official title: Ferredoxin--NAD+ reductase (1.18.1.3)
C12Y118/01003 (Ferredoxin--nad+ reductase) appears on 1 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 5
- Assignees
- 6
- Inventors
- 19
- Latest grant
- 25 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 2 |
By publication year.
Recent patents
- Composition for preparing retinoid, and method for preparing retinoid using same24 Apr 2025US 2025/0129403 A1Industry-Academic Cooperation Foundation Gyeongsang National University
- Fusion polypeptides for production of 7-dehydrocholesterol and methods of use thereof6 Feb 2025US 2025/0043252 A1Hangzhou Enhe Biotechnology Co., Ltd.
- Polynucleotide and expression cassette comprising coding sequence of toluene dioxygenase, and use thereof12 Sep 2024US 2024/0301369 A1Shanghai Shengping Medical Equipment Co., Ltd.
- Method for preparation of 2,6-bis(hydroxymethyl)pyridine via enzymatic catalysis10 Aug 2023US 2023/0250456 A1
- Electron transport chain module from eukaryotic organelle and application thereof7 Nov 2019US 2019/0338257 A1Peking University
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.